FoxA1, also known as hepatocyte nuclear factor HNF-3-alpha, is a key partner for ERα and AR in promoting transcriptional activity in breast and prostate cancer, respectively, and recognizes the FKH motif. This evidence concerns the gene AR and prostate carcinoma.